Clinical cure rate of inactive HBsAg carriers with HBsAg <200 IU/ml treated with pegylated interferon

Li, H; Liang, S; Liu, LL; Zhou, DQ; Liu, YL; Zhang, Y; Chen, XY; Zhang, J; Cao, ZH

Zhang, J; Cao, ZH (通讯作者)，Capital Med Univ, Beijing Youan Hosp, Dept Hepatol, Unit 3, Beijing, Peoples R China.

FRONTIERS IN IMMUNOLOGY, 2022; 13 ():

Abstract

PurposeHBsAg clearance represents clinical cure for patients with hepatitis B, but remains difficult to obtain for most HBV-infected patients. Recent ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索